Seed Round - RealSeq Biosciences
Investment Firm
Overview
RealSeq Biosciences’ core expertise includes innovative proprietary technologies for bias-free small RNA/miRNA NGS library construction.
Announced Date
Mar 11, 2024
Closed on Date
Mar 01, 2024
Funding Type
Seed
Highlights
Location
United States, North America
Social
Participant Investors
2
| Investor Name |
|---|
 Charleston Angel Partners |
Round Details and Background
RealSeq Biosciences raised an undisclosed amount on 2024-03-11 in Seed Round
RealSeq Biosciences’ core expertise includes innovative proprietary technologies for bias-free small RNA/miRNA NGS library construction.
Company Funding History
3
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Jul 06, 2022 |  Non Equity Assistance - RealSeq Biosciences | 1 | - | undefined |
| Jul 28, 2023 | Seed Round - RealSeq Biosciences | 5 | - | 1.5M |
| Mar 11, 2024 | Seed Round - RealSeq Biosciences | 3 | - | undefined |
Recent Activity
News
Mar 13, 2024
FinSMEs - RealSeq Biosciences Extends Seed Funding
News
Mar 11, 2024
EIN News - RealSeq Biosciences Secures Additional Funding to Advance RNA Technologies for Biomarker Discovery and Liquid Biopsy
News
Mar 11, 2024
RealSeq Biosciences Secures Additional Funding to Advance RNA Technologies for Biomarker Discovery and Liquid Biopsy
News
Mar 11, 2024
Queen City News - RealSeq Biosciences Secures Additional Funding to Advance RNA Technologies for Biomarker Discovery and Liquid Biopsy